Atypical dementia associated with a novel presenilin-2 mutation
Corresponding Author
Giuliano Binetti MD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Neurobiology Lab and Memory Clinic, IRCCS - Fatebenefratelli, via Pilastroni 4, 25123 Brescia, ItalySearch for more papers by this authorSimona Signorini PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorRosanna Squitti PhD
Neuroscience Department AFaR Fatebenefratelli Hospital, Rome
Search for more papers by this authorAntonella Alberici MD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorLuisa Benussi PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorEmanuele Cassetta MD
Neuroscience Department AFaR Fatebenefratelli Hospital, Rome
Search for more papers by this authorGiovanni Battista Frisoni MD
Laboratory of Epidemiology and Neuroimaging, Brescia
Search for more papers by this authorLaura Barbiero PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorEnrica Feudatari PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorFrancesca Nicosia PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorCristina Testa PhD
Laboratory of Epidemiology and Neuroimaging, Brescia
Search for more papers by this authorOrazio Zanetti MD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorMassimo Gennarelli PhD
Genetics Unit, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorDaniela Perani MD
Vita-Salute San Raffaele University and IBFM-CNR
Search for more papers by this authorDavide Anchisi MD
Scientific Institute Hospital San Raffaele, Milan
Search for more papers by this authorRoberta Ghidoni PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorPaolo Maria Rossini MD
Neuroscience Department AFaR Fatebenefratelli Hospital, Rome
Neurology, University Campus Bio-Medico, Rome, Italy
Search for more papers by this authorCorresponding Author
Giuliano Binetti MD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Neurobiology Lab and Memory Clinic, IRCCS - Fatebenefratelli, via Pilastroni 4, 25123 Brescia, ItalySearch for more papers by this authorSimona Signorini PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorRosanna Squitti PhD
Neuroscience Department AFaR Fatebenefratelli Hospital, Rome
Search for more papers by this authorAntonella Alberici MD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorLuisa Benussi PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorEmanuele Cassetta MD
Neuroscience Department AFaR Fatebenefratelli Hospital, Rome
Search for more papers by this authorGiovanni Battista Frisoni MD
Laboratory of Epidemiology and Neuroimaging, Brescia
Search for more papers by this authorLaura Barbiero PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorEnrica Feudatari PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorFrancesca Nicosia PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorCristina Testa PhD
Laboratory of Epidemiology and Neuroimaging, Brescia
Search for more papers by this authorOrazio Zanetti MD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorMassimo Gennarelli PhD
Genetics Unit, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorDaniela Perani MD
Vita-Salute San Raffaele University and IBFM-CNR
Search for more papers by this authorDavide Anchisi MD
Scientific Institute Hospital San Raffaele, Milan
Search for more papers by this authorRoberta Ghidoni PhD
Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, Brescia
Search for more papers by this authorPaolo Maria Rossini MD
Neuroscience Department AFaR Fatebenefratelli Hospital, Rome
Neurology, University Campus Bio-Medico, Rome, Italy
Search for more papers by this authorAbstract
We describe an Italian pedigree with hereditary dementia associated with a novel T122R mutation in the presenilin-2 gene (PSEN2). The clinical history, symptom presentation, and structural neuroimaging were consistent with an atypical form of dementia. Disease expression varied within family members. One in a pair of mutated monozygotic twins had evident signs of disease, whereas the other did not, even if her functional neuroimaging investigations, cerebrospinal fluid levels of Aβ1-42, and Tau protein were able to provide markers for future disease development. These observations suggest the importance of still unknown biological and perhaps environmental factors in the disease determination.
References
- 1 Crutz M, van Duijin CM, Backhovens H, et al. Estimation of the genetic contribution of presenilin-1 and –2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7: 43–51.
- 2 Crook R, Verkkoniemi A, Perez-Tur J, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 1998; 4: 452–455.
- 3 Tang-Wai D, Lewis P, Boeve B, et al. Familial frontotemporal dementia associated with a novel presenilin-1 mutation. Dement Geriatr Cogn Disord 2002; 14: 13–21.
- 4 Amtul Z, Lewis PA, Piper S, et al. A presenilin-1 associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiol Dis 2002; 9: 289–293.
- 5 Tedde A, Forleo P, Nacmias B, et al. A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset. Neurology 2000; 55: 1590–1591.
- 6 Finckh U, Alberici A, Antoniazzi M, et al. Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology 2000; 54: 2006–2008.
- 7 Sherrington R, Froelich S, Campion D, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Gen 1996; 5: 985–988.
- 8 Binetti G, Magni E, Padovani A, et al. Executive dysfunction in early Alzheimer's disease. J Neurosurg Psychiatry 1996; 60: 91–93.
- 9 Signorini M, Paulesu E, Friston K, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. NeuroImage 1999; 9: 63–80.
- 10 Sjogren M, Vanderstichele H, Agren H, et al. Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values. Clin Chem 2001; 47: 1776–1781.
- 11 The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57: 416–418.
- 12 Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001; 24: 121–159.
- 13 Lippa CF, Swearer JM, Kane KJ, et al. Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol 2000; 48: 376–379.
- 14 Fox NC, Kennedy AM, Harvey RJ, et al. Clinocopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin-1 gene: pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 1997; 120: 491–501.
- 15 Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258: 806–808.
- 16 Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage 2002; 17: 302–316.